Assertio Holdings Crecimiento futuro

Future controles de criterios 0/6

Se prevé que los ingresos de Assertio Holdings disminuyan a un ritmo anual de 4.9%, mientras que se prevé que sus beneficios anuales crezcan a un ritmo de 153.3% por año. Se espera que el BPA crezca en un 153.9% al año.

Información clave

153.3%

Tasa de crecimiento de los beneficios

153.9%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	27.6%
Tasa de crecimiento de los ingresos	-4.9%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	28 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 07

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Apr 18

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Mar 13

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Apr 26

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Mar 02

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:ASRT - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	129	-2	31	33	3
12/31/2024	121	-16	15	17	3
3/31/2024	142	-333	33	34	N/A
12/31/2023	152	-332	49	50	N/A
9/30/2023	169	-186	44	71	N/A
6/30/2023	168	98	51	78	N/A
3/31/2023	162	97	32	74	N/A
12/31/2022	156	110	36	79	N/A
9/30/2022	139	26	21	56	N/A
6/30/2022	130	25	16	51	N/A
3/31/2022	121	3	18	37	N/A
12/31/2021	111	-1	-13	6	N/A
9/30/2021	110	-30	-5	-5	N/A
6/30/2021	119	-44	-24	-24	N/A
3/31/2021	114	-65	-44	-45	N/A
12/31/2020	108	-28	303	-66	N/A
9/30/2020	135	-196	317	-52	N/A
6/30/2020	156	-183	365	-3	N/A
3/31/2020	192	-162	405	38	N/A
12/31/2019	230	-217	89	90	N/A
9/30/2019	157	-49	95	98	N/A
6/30/2019	180	-4	130	135	N/A
3/31/2019	186	-11	121	127	N/A
12/31/2018	256	37	67	72	N/A
9/30/2018	364	28	80	84	N/A
6/30/2018	381	-36	9	10	N/A
3/31/2018	419	-42	19	19	N/A
12/31/2017	381	-102	N/A	62	N/A
9/30/2017	410	-114	N/A	76	N/A
6/30/2017	425	-111	N/A	96	N/A
3/31/2017	442	-95	N/A	103	N/A
12/31/2016	456	-89	N/A	71	N/A
9/30/2016	443	-75	N/A	88	N/A
6/30/2016	437	-74	N/A	120	N/A
3/31/2016	415	-85	N/A	130	N/A
12/31/2015	343	-76	N/A	152	N/A
9/30/2015	426	50	N/A	89	N/A
6/30/2015	373	68	N/A	40	N/A
3/31/2015	346	102	N/A	7	N/A
12/31/2014	390	132	N/A	-56	N/A
9/30/2014	236	79	N/A	-60	N/A
6/30/2014	222	79	N/A	-45	N/A
3/31/2014	185	67	N/A	-51	N/A
12/31/2013	134	43	N/A	10	N/A
9/30/2013	120	-2	N/A	5	N/A
6/30/2013	116	-10	N/A	-10	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que ASRT siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que ASRT siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que ASRT siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de ASRT disminuyan en los próximos 3 años (-4.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de ASRT disminuyan en los próximos 3 años (-4.9% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de ASRT se prevé que sea elevada dentro de 3 años.

Assertio Holdings Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

Consensus revenue estimates fall by 27%

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Consensus EPS estimates fall by 18%

Consensus revenue estimates increase by 13%, EPS downgraded

Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023

Recent updates

Assertio Holdings, Inc. Announces the Appointment of Brendan P. O’Grady as CEO

The Buxton Helmsley Group Sends Letter to Assertio Holdings

The Buxton Helmsley Group Sends Letter to Assertio Holdings

Assertio Holdings, Inc. Reiterates Earnings Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Assertio Holdings, Inc. to Report Q1, 2024 Results on May 06, 2024

Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?

Assertio Holdings, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 27%

Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified

Full year 2023 earnings: EPS misses analyst expectations

Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024

Assertio Holdings, Inc. to Report Q4, 2023 Results on Mar 11, 2024

New major risk - Share price stability

Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors

Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against Assertio Holdings, Inc

Assertio Holdings, Inc. Announces Executive Changes

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

New minor risk - Market cap size

Assertio Holdings, Inc. Announces CFO Changes

New minor risk - Profitability

Consensus EPS estimates fall by 18%

Assertio Holdings, Inc. to Report Q3, 2023 Results on Nov 08, 2023

President recently sold US$479k worth of stock

President notifies of intention to sell stock

New major risk - Shareholder dilution

Independent Director notifies of intention to sell stock

New minor risk - Share price stability

Assertio Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $25 million.

Consensus revenue estimates increase by 13%, EPS downgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023

Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).

Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors

Assertio Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Independent Director recently sold US$652k worth of stock

President exercised options and sold US$2.9m worth of stock

Consensus EPS estimates fall by 30%, revenue upgraded

Assertio Holdings, Inc. Raises Earnings Guidance for the Full Year of 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 17%

We Think Assertio Holdings (NASDAQ:ASRT) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued

Price target increased by 9.6% to US$7.88

Is There An Opportunity With Assertio Holdings, Inc.'s (NASDAQ:ASRT) 23% Undervaluation?

Investor sentiment improves as stock rises 18%

Consensus EPS estimates increase by 164%

President exercised options and sold US$257k worth of stock

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 11%

Investor sentiment deteriorated over the past week

Insufficient new directors

Assertio Holdings, Inc. Revises Net Product Sales Guidance for the Year 2022

Assertio Holdings, Inc. Revises Earnings Guidance for the Full Year 2022

Assertio Holdings, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Assertio Holdings Looks Good To Rebound After Recent Price Plunge

Assertio Holdings: Substantial Upside

Assertio Holdings, Inc. Raises Earnings Guidance for the Year 2022

Assertio Therapeutics Q2 2022 Earnings Preview

Assertio Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Assertio Holdings: Management Still Swimming Against The Tide

Assertio's Phenomenal Turnaround

Assertio Holdings, Inc. Re-Affirms Sales Guidance for the Full Year of 2022

Levi & Korsinsky, LLP Announces Propose Settlement Against Assertio Therapeutics, Inc. Securities Litigation

Assertio Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Assertio Holdings: Recent Breakout To Lead To Sustained Gains